Filgrastim Completed Phase 2 Trials for Bladder Cancers / Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00028860Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer
NCT00002919Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer